Skip to main content

Table 2 Time course of clinical, paraclinical and laboratory evaluations

From: Impact of superimposed nephrological care to guidelines-directed management by primary care physicians of patients with stable chronic kidney disease: a randomized controlled trial

Months

0

6

12

18

24

Clinical evaluation

 Charlson’s comorbidity score

X

    

 Clinical events (hospitalization, death, emergency RRT)

  

X

 

X

 Kidney Disease Quality of Life questionnaire

X

 

X

 

X

Paraclinical evaluation

 Echocardiography (LVH and EF)

X

 

X

 

X

 Targeted BP (24 h monitoring)

X

 

X

 

X

Laboratory evaluation

 24 h proteinuria and creatininuria

X

 

X

 

X

 eGFR

X

 

X

 

X

 Ferritin and transferrin saturation

X

 

X

 

X

 B12 and folate

X

 

X

 

X

 Albumin

X

 

X

 

X

 PTH, calcium, phosphate, bicarbonate

X

 

X

 

X

 BNP and NT pro-BNP

X

 

X

 

X

 Cholesterol and triglycerides

X

 

X

 

X

 CRP and IL-6

X

 

X

 

X